Bohai Pharmaceuticals Group Inc. BOPH Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Bohai Pharmaceuticals Group Inc. BOPH Company Overview 

Stock Message Board http://investorshangout.com/search?q=BOPH&...mp;yt1=Go!

Bohai Pharmaceuticals Group Inc. BOPH Current Price and Quotes
0.48
Previous Close
0.41
Open
0.48

Daily Range
0.48 - 0.48
52wk Range
0.85 - 0.37

Volume
5,500
Dividend
N/A

Average Vol (3m)
4,942
Yield
N/A

Bohai Pharmaceuticals Group Inc. BOPH
Company Information
Yantai Bohai Pharmaceuticals Group Co.
No. 9 Daxin Road, Zhifu District
Yantai
Shandong Province 264000
China

Phone: +86(535)-685-7928

Bohai Pharmaceuticals Group Inc. BOPH
Bohai Pharmaceuticals Group Inc. BOPH
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Mar 31, 2013 10-Q
CIK 0001443242
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Hongwei Qui President, CEO
Chunhong Jiang Secretary, Treasurer
Company Directors
Hongwei Qui Chairman
Thomas Tan
Company Notes
Formerly=Link Resources, Inc. until 2-2010
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Ellenoff Grossman & Schole LLP
150 East 42nd Street
New York, NY, 10017
United States

Investor Relations Firm
Not Available

Bohai Pharmaceuticals Group Inc. BOPH
BOPH Security Details
Share Structure
Market Value1 $7,323,045 a/o Sep 03, 2013
Shares Outstanding 17,861,085 a/o May 15, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders
Shareholders of Record 65 a/o Sep 28, 2011
Short Selling Data
Short Interest 2,500 (100%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)


Bohai Pharmaceuticals Group Inc. BOPH Recent News

Bohai Pharmaceuticals Group Inc. BOPH Financials
Period Ending Jun 30, 2012 Jun 30, 2011 Jun 30, 2010 May 31, 2009
Total Revenue 137,372 81,329 59,265 49,349
Cost of Revenue 33,533 17,294 10,165 7,975
Gross Profit 103,840 64,035 49,100 41,373
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 72,890 45,550 36,253 31,347
Non-Recurring Items - - - -
Other 2,578 229 - -
Operating Income 28,371 18,256 12,847 10,026
Income From Continuing Operations
Add'l Income/Expense Items (214) 4,612 1,052 13
Earnings Before Interest and Tax 28,157 22,868 13,898 10,039
Interest Expense 11,194 4,098 1,437 184
Earnings Before Tax 16,963 18,770 12,461 9,855
Income Tax 7,315 4,765 3,405 2,337
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 9,648 14,005 9,057 7,517
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 9,648 14,005 9,057 7,517
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 9,648 14,005 9,057 7,517

BOPH Bohai Pharmaceuticals Group Inc. Research DD Guide

BOPH Bohai Pharmaceuticals Group Inc. Stock Message Board http://investorshangout.com/search?q=BOPH&...mp;yt0=Go!
BOPH Bohai Pharmaceuticals Group Inc. Stock Quote http://www.otcmarkets.com/stock/BOPH/quote
BOPH Bohai Pharmaceuticals Group Inc. Stock Chart http://www.otcmarkets.com/stock/BOPH/chart
BOPH Bohai Pharmaceuticals Group Inc. Company Info http://www.otcmarkets.com/stock/BOPH/company-info
BOPH Bohai Pharmaceuticals Group Inc. Recent News http://www.otcmarkets.com/stock/BOPH/news
BOPH Bohai Pharmaceuticals Group Inc. Financials http://www.otcmarkets.com/stock/BOPH/financials
BOPH Bohai Pharmaceuticals Group Inc. Filings and Disclosure http://www.otcmarkets.com/stock/BOPH/filings
BOPH Bohai Pharmaceuticals Group Inc. Short Sales http://www.otcmarkets.com/stock/BOPH/short-sales
BOPH Bohai Pharmaceuticals Group Inc. Insider Disclosure http://www.otcmarkets.com/stock/BOPH/insider-transactions
BOPH Bohai Pharmaceuticals Group Inc. Research Reports http://www.otcmarkets.com/stock/BOPH/research
BOPH Bohai Pharmaceuticals Group Inc. Summary http://finance.yahoo.com/q?s=BOPH
BOPH Bohai Pharmaceuticals Group Inc. Historical Prices http://finance.yahoo.com/q/hp?s=BOPH+Historical+Prices
BOPH Bohai Pharmaceuticals Group Inc. Interactive Chart http://finance.yahoo.com/echarts?s=BOPH
BOPH Bohai Pharmaceuticals Group Inc. Basic Chart http://finance.yahoo.com/q/bc?s=BOPH+Basic+Chart
BOPH Bohai Pharmaceuticals Group Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BOPH+Basic+Tech.+Analysis
BOPH Bohai Pharmaceuticals Group Inc. Headlines http://finance.yahoo.com/q/h?s=BOPH+Headlines
BOPH Bohai Pharmaceuticals Group Inc. Press Releases http://finance.yahoo.com/q/p?s=BOPH+Press+Releases
BOPH Bohai Pharmaceuticals Group Inc. Company Profile http://finance.yahoo.com/q/pr?s=BOPH+Profile
BOPH Bohai Pharmaceuticals Group Inc. Key Statistics http://finance.yahoo.com/q/ks?s=BOPH+Key+Statistics
BOPH Bohai Pharmaceuticals Group Inc. Industry http://finance.yahoo.com/q/in?s=BOPH+Industry
BOPH Bohai Pharmaceuticals Group Inc. Major Holders http://finance.yahoo.com/q/mh?s=BOPH+Major+Holders
BOPH Bohai Pharmaceuticals Group Inc. Insider Transactions http://finance.yahoo.com/q/it?s=BOPH+Insider+Transactions
BOPH Bohai Pharmaceuticals Group Inc. Insider Roster http://finance.yahoo.com/q/ir?s=BOPH+Insider+Roster
BOPH Bohai Pharmaceuticals Group Inc. Income Statement http://finance.yahoo.com/q/is?s=BOPH
BOPH Bohai Pharmaceuticals Group Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=BOPH
BOPH Bohai Pharmaceuticals Group Inc. Cash Flow http://finance.yahoo.com/q/cf?s=BOPH+Cash+Flow&annual
BOPH Bohai Pharmaceuticals Group Inc. Nasdaq http://www.nasdaq.com/symbol/BOPH
BOPH Bohai Pharmaceuticals Group Inc. Market Watch http://www.marketwatch.com/investing/stock/BOPH
BOPH Bohai Pharmaceuticals Group Inc. Bloomberg http://www.bloomberg.com/quote/BOPH:US
BOPH Bohai Pharmaceuticals Group Inc. Morningstar http://quotes.morningstar.com/stock/s?t=BOPH
BOPH Bohai Pharmaceuticals Group Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=BOPH
BOPH Bohai Pharmaceuticals Group Inc. Barchart http://www.barchart.com/quotes/stocks/BOPH
BOPH Bohai Pharmaceuticals Group Inc. OTC Short Report http://otcshortreport.com/index.php?index=BOPH
BOPH Bohai Pharmaceuticals Group Inc. Investopedia http://www.investopedia.com/markets/stocks/BOPH/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Valour Inc. Unveils Advanced Leveraged ETPs for Crypto Trading

Updated Category News Views 86

Valour Inc. Launches Innovative Leveraged ETPs Valour Inc., a subsidiary of DeFi Technologies, is making waves in the financial technology sector by launching leveraged exchange-traded products (ETPs) focused on Bitcoin and Ethereum. These new offerings, titled Bull Bitcoin X2 Valour and Bull Ethereum X2 Valour, deliver twice the daily exposure to these leading...

Continue Reading
Inhibikase Therapeutics Makes Headway with $275 Million Financing

Updated Category News Views 84

Introduction to Inhibikase Therapeutics Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is a pioneering clinical-stage pharmaceutical company dedicated to creating innovative therapeutics for cardiopulmonary and neurodegenerative diseases. Their commitment to developing high-quality treatments is evident in the recent announcement regarding an impressive financing deal....

Continue Reading
JBS USA Food Company's Successful Tender Offer for Notes

Updated Category News Views 341

Overview of the Tender Offer by JBS USA Food Company JBS USA Food Company recently shared exciting news about the successful conclusion of its cash tender offer for its 2.500% Senior Notes due 2027. The offer was designed for any and all outstanding notes, aimed at strengthening the company's financial position. Details on Tender Offer Results As reported, the results...

Continue Reading
Imaflex's Impressive Q2 2025 Results Show Resilience

Updated Category News Views 114

Strong Balance Sheet and Operational Agility Support Future Growth In a world where market dynamics can shift unexpectedly, Imaflex Inc. is finding ways to maintain robust performance despite the prevailing challenges. The company recently released its financial results for the second quarter of 2025 with notable highlights that showcase its resilience and strategic...

Continue Reading
A Decade of Growth: The Journey of Penumbra Stock Value

Updated Category News Views 158

Understanding Penumbra's Growth Over the Last Decade Penumbra (NYSE: PEN) has shown remarkable growth over the past decade, achieving an annualized return of 20.49%. This performance eclipses the market by an impressive 7.83% annually, making it a notable player in the healthcare sector. The Impact of Compounding Returns When it comes to investing, one fundamental...

Continue Reading